Xie X, Li Y, Lv Q, Wang W, et al. Immune-related adverse events correlate with the clinical efficacy in advanced Non-Small-Cell Lung Cancer patients treated with PD-1 inhibitors combination therapy. BMC Cancer 2024;24:1541.
PMID: 39696102